These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 37981676)

  • 1. Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.
    Novy E; Roger C; Roberts JA; Cotta MO
    Crit Care; 2023 Nov; 27(1):449. PubMed ID: 37981676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of serum and peritoneal 1.3-beta-D-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study.
    Novy E; Rivière J; Nguyen M; Arfeuille G; Louis G; Bouhemad B; Pottecher J; Hecketsweiler S; Germain A; Laithier FX; Losser MR; Debourgogne A; Bernard Y; Rousseau H; Baumann C; Luc A; Birckener J; Machouart MC; Guerci P
    Crit Care; 2023 Nov; 27(1):470. PubMed ID: 38037130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What´s new in intraabdominal candidiasis in critically ill patients, a review.
    Lagunes L; Rey-Pérez A
    Hosp Pract (1995); 2019 Oct; 47(4):171-176. PubMed ID: 31585520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis.
    Yan T; Li SL; Ou HL; Zhu SN; Huang L; Wang DX
    World J Surg; 2020 May; 44(5):1459-1469. PubMed ID: 31965275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment.
    Vergidis P; Clancy CJ; Shields RK; Park SY; Wildfeuer BN; Simmons RL; Nguyen MH
    PLoS One; 2016; 11(4):e0153247. PubMed ID: 27123857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients.
    Peçanha-Pietrobom PM; Colombo AL
    Curr Opin Infect Dis; 2020 Dec; 33(6):441-448. PubMed ID: 33044240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical appraisal beyond clinical guidelines for intraabdominal candidiasis.
    Maseda E; Martín-Loeches I; Zaragoza R; Pemán J; Fortún J; Grau S; Aguilar G; Varela M; Borges M; Giménez MJ; Rodríguez A
    Crit Care; 2023 Oct; 27(1):382. PubMed ID: 37789338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of choice of initial antifungal treatment in intraabdominal candidiasis.
    Lagunes L; Borgatta B; Martín-Gomez MT; Rey-Pérez A; Antonelli M; Righi E; Merelli M; Brugnaro P; Dimopoulos G; Garnacho-Montero J; Colombo AL; Luzzati R; Menichetti F; Muñoz P; Nucci M; Scotton G; Viscoli C; Tumbarello M; Bassetti M; Rello J;
    Clin Microbiol Infect; 2016 Aug; 22(8):719-24. PubMed ID: 27432766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A; Ferriols-Lisart R; Aguilar G; Ezquer-Garín C; Belda FJ; Guglieri-López B
    Int J Antimicrob Agents; 2018 Jan; 51(1):115-121. PubMed ID: 28666752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of fluconazole in critically ill patients.
    Sinnollareddy M; Peake SL; Roberts MS; Playford EG; Lipman J; Roberts JA
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1431-40. PubMed ID: 21883033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.
    Bassetti M; Marchetti M; Chakrabarti A; Colizza S; Garnacho-Montero J; Kett DH; Munoz P; Cristini F; Andoniadou A; Viale P; Rocca GD; Roilides E; Sganga G; Walsh TJ; Tascini C; Tumbarello M; Menichetti F; Righi E; Eckmann C; Viscoli C; Shorr AF; Leroy O; Petrikos G; De Rosa FG
    Intensive Care Med; 2013 Dec; 39(12):2092-106. PubMed ID: 24105327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic and therapeutic approach of intraabdominal candidiasis].
    Montero A; Gilsanz F; Maseda E
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():52-5. PubMed ID: 27608315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
    Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
    Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins].
    Almirante B; Garnacho-Montero J; Maseda E; Candel FJ; Grau S; Guinea J; Moreno I; Muñoz P; Ruiz-Santana S
    Rev Esp Quimioter; 2017 Oct; 30(5):355-367. PubMed ID: 28945064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualized antifungal therapy in critically ill patients with invasive fungal infection].
    Zaragoza R; Maseda E; Pemán J
    Rev Iberoam Micol; 2021; 38(2):68-74. PubMed ID: 34301466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/Pharmacodynamic Target Attainment of Different Antifungal Agents in De-escalation Treatment in Critically Ill Patients: a Step toward Dose Optimization Using Monte Carlo Simulation.
    Xie J; Yang Q; Han X; Dong Y; Zhang T; Li Y; Ji M; Liu C; Cai Y; Wang Y
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0009922. PubMed ID: 35604209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.
    Montravers P; Dupont H; Eggimann P
    Intensive Care Med; 2013 Dec; 39(12):2226-30. PubMed ID: 24154676
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?
    Wang Y; McGuire TM; Hollingworth SA; Dong Y; Van Driel ML
    Int J Infect Dis; 2019 Dec; 89():137-145. PubMed ID: 31639522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM; van der Elst KC; Veringa A; Jongedijk EM; Brüggemann RJ; Koster RA; Kampinga GA; Kosterink JG; van der Werf TS; Zijlstra JG; Touw DJ; Alffenaar JWC
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay.
    Maseda E; Rodríguez AH; Aguilar G; Pemán J; Zaragoza R; Ferrer R; Llinares P; Grau S;
    Rev Iberoam Micol; 2016; 33(4):196-205. PubMed ID: 27422492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.